CASE STUDIES

    Liposomal Preclinical Development Formulations

    [grid class='gutter']

    [col-6-8]

    Product Development of a Liposomal Antifungal Ophthalmic Formulation – Screening Studies

    A client solicited our collaboration in development of a liposomal platform to meet a new clinical need for an antifungal API.

    [/col][col-2-8]

    Read

    [/col][/grid]

     


     

    [grid class='gutter']

    [col-6-8]

    Process Optimization for a Liposomal Product – A Potential Metabolic Replacement Therapy Candidate

    A client is currently developing a liposomal formulation of a hydrophilic small molecule API.

    [/col][col-2-8]

    Read

    [/col][/grid]

     


     

    [grid class='gutter']

    [col-6-8]

    Formulation Optimization of a Hydrophilic Small Molecule Liposomal Product

    The client has developed the liposomal formulation of a hydrophilic small molecule drug using unsaturated phospholipids and ethanol injection method.

    [/col][col-2-8]

    Read

    [/col][/grid]

     


     

    [grid class='gutter']

    [col-6-8]

    Process Development of an RNA Oligonucleotide-Based Lipid Nanoparticle Formulation

    A client is developing a new Lipid Nanoparticle (LNP) formulation encapsulating a short RNA oligonucleotide.

    [/col][col-2-8]

    Read

    [/col][/grid]